[ Price : $8.95]
Speaking at a BIO International Convention FDA Town Hall, several agency executives cite increases in hiring and decreases in attr...[ Price : $8.95]
A new analysis published in JAMA Psychiatry raises fresh questions about how FDA evaluates drug efficacy when clinical trial resul...[ Price : $8.95]
FDA grants Pfizer expanded approval for Ibrance in combination with trastuzumab, with or without pertuzumab, and endocrine therapy...[ Price : $8.95]
FDA publishes a report summarizing demographic information from pivotal trials supporting 46 novel new drugs approved in 2025.[ Price : $8.95]
The Trump Administration considers White House health policy adviser Heidi Overton as a leading candidate to become the next FDA c...[ Price : $8.95]
JAMA publishes a controversial Covid-19 vaccine effectiveness study, which was previously blocked from publication in a Centers fo...[ Price : $8.95]
Eight Hyman, Phelps & McNamara attorneys analyze a House Appropriations Committee report that explains its rationale and expectati...[ Price : $8.95]
The Federal Trade Commission files an amicus brief supporting plaintiffs in an antitrust lawsuit accusing Johnson & Johnson of unl...